Granules India Buyback – Ray Of Hope During Coronavirus Turmoil?

Q4 Impacted By Export Restrictions

Granules India’s buyback offer seems to be timed right. As the novel coronavirus crisis batters the Indian stock market, a 32% premium offered by the company is an attractive proposition for investors. However, its Q4 performance will see a blip on account of paracetamol export restrictions.

Pandemic
Will Granules Prove To Be A Good Bet? • Source: Shutterstock

At a time when the possibility of an economic slowdown led by the coronavirus crisis sends stocks into a sea of red across global stock markets, including in India, Granules India Ltd.’s buy-back offer might look like a ray of hope to Indian investors.

On 16 March, the barometer 30-scrip sensitive index (Sensex) of the Bombay Stock Exchange (BSE) closed at 31,390.07, down 8%...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip